pAT222
(Plasmid
#40942)
-
Depositing Lab
-
Publication
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 40942 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepAFS135
-
Backbone manufacturerAndrew W. Murray Lab, UCSF (Straight, Sedat, & Murray, 1998. PMID: 9813090)
- Backbone size w/o insert (bp) 5650
- Total vector size (bp) 7484
-
Modifications to backboneHIS3 marker of pAT123 substituted with a LEU2-containing ScaI-DraIII fragment from pRS405
-
Vector typeYeast Expression
-
Selectable markersLEU2
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberUnknown
Gene/Insert
-
Gene/Insert nameGFP-LacI**
-
Alt nameGFP-LacI
-
Alt nameLacI2G(4mutations)
-
Alt nameLacI
-
SpeciesE. coli
-
Insert Size (bp)1850
-
MutationLacI**/LacI2G(4 mutations) (see comment below); lacI-I12 mutation (P3Y); C-terminal 11 amino acids deleted to prevent tetramerization
- Promoter His3 promoter fragment
-
Tags
/ Fusion Proteins
- GFP(S65T, V163A) (N terminal on insert)
- SV40 NLS (C terminal on insert)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site XhoI (not destroyed)
- 3′ cloning site XbaI (not destroyed)
- 5′ sequencing primer GFP-F, M13_pUC_rev
- 3′ sequencing primer M13_pUC_fwd (Common Sequencing Primers)
Resource Information
-
A portion of this plasmid was derived from a plasmid made byLEU2-containing pRS405 ScaI-DraIII fragment from Karine Dubrana and Susan Gasser.
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
The plasmid pAFS135 (Straight, Sedat, and Murray, 1998) contains GFP(S65T, V163A)-LacI(P3Y, del C-terminal 11 aa)-SV40 NLS under the control of a HIS3 promoter fragment. To construct pAT123, the HIS3 marker of AFS135 was replaced with a ScaI-DraIII fragment from RS405 containing LEU2 (a kind gift from Karine Dubrana and Susan Gasser).
The plasmid pAT222 was obtained by site-directed mutagenesis of pAT123 to create GFP-LacI**, using the primers (base mutations in lowercase):
5’- GTGGCACAgCAACTGGCGGaCAAAggtggcggaTCGTTGCTGATTGGCGTTGCCtCCT-3’ and
5’- AGGaGGCAACGCCAATCAGCAACGAtccgccaccTTTGtCCGCCAGTTGcTGTGCCAC- 3’.
Alternate plasmid name: pAT123LacI2G(4mutations)
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pAT222 was a gift from Angela Taddei (Addgene plasmid # 40942 ; http://n2t.net/addgene:40942 ; RRID:Addgene_40942) -
For your References section:
Tight protein-DNA interactions favor gene silencing. Dubarry M, Loiodice I, Chen CL, Thermes C, Taddei A. Genes Dev. 2011 Jul 1;25(13):1365-70. 10.1101/gad.611011 PubMed 21724830